HLA-DPB1 mismatch reduce relapse and improve survival in T-cell replete unrelated donor allogeneic stem cell transplantation

B Grønvold¹, M M Ali², M Remberger^{2

3}, J Mattsson⁴, T Egeland^{5

6}, K U Lundin⁵, A E Myhre², I W Abrahamsen², D Heldal², I Dybedal², G E Tjønnfjord^{2

6}, Y Fløisand^#^{2

7}, T Gedde-Dahl^#^{2

6}

Affiliations

¹ Department of Haematology, Oslo University Hospital, Oslo, Norway. bjoegr@ous-hf.no.
² Department of Haematology, Oslo University Hospital, Oslo, Norway.
³ Department of Medical Sciences, Uppsala University and KFUE, Uppsala University Hospital, Uppsala, Sweden.
⁴ Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
⁵ Institute of Immunology, Oslo University Hospital, Oslo, Norway.
⁶ Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
⁷ Centre for Cancer Cell Reprogramming, Department of Molecular Cell Biology, Oslo University Hospital, Oslo, Norway.

^# Contributed equally.

B Grønvold et al. Bone Marrow Transplant. 2020 Aug.

. 2020 Aug;55(8):1658-1661.

doi: 10.1038/s41409-020-0827-3. Epub 2020 Feb 13.

¹ Department of Haematology, Oslo University Hospital, Oslo, Norway. bjoegr@ous-hf.no.
² Department of Haematology, Oslo University Hospital, Oslo, Norway.
³ Department of Medical Sciences, Uppsala University and KFUE, Uppsala University Hospital, Uppsala, Sweden.
⁴ Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada.
⁵ Institute of Immunology, Oslo University Hospital, Oslo, Norway.
⁶ Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
⁷ Centre for Cancer Cell Reprogramming, Department of Molecular Cell Biology, Oslo University Hospital, Oslo, Norway.

^# Contributed equally.

No abstract available

References

1. Solomon SR, Sizemore CA, Zhang X, Brown S, Holland HK, Morris LE, et al. Impact of donor type on outcome after allogeneic hematopoietic cell transplantation for acute leukemia. Biol Blood Marrow Transpl. 2016;22:1816–22. https://doi.org/10.1016/j.bbmt.2016.07.010 . - DOI
1. Morishima Y, Kashiwase K, Matsuo K, Azuma F, Morishima S, Onizuka M, et al. Biological significance of HLA locus matching in unrelated donor bone marrow transplantation. Blood. 2015;125:1189–97. https://doi.org/10.1182/blood-2014-10-604785 . - DOI - PubMed - PMC
1. Howard CA, Fernandez-Vina MA, Appelbaum FR, Confer DL, Devine SM, Horowitz MM, et al. Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN). Biol Blood Marrow Transpl. 2015;21:4–7. https://doi.org/10.1016/j.bbmt.2014.09.017 . - DOI
1. Fleischhauer K, Shaw BE. HLA-DP in unrelated hematopoietic cell transplantation revisited: challenges and opportunities. Blood. 2017;130:1089–96. https://doi.org/10.1182/blood-2017-03-742346 . - DOI - PubMed
1. Petersdorf EW, Gooley T, Malkki M, Anasetti C, Martin P, Woolfrey A, et al. The biological significance of HLA-DP gene variation in haematopoietic cell transplantation. Br J Haematol. 2001;112:988–94. - DOI